✦ LIBER ✦

Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial

✍ Scribed by O. Chosidow; Y. Drouault; F. Leconte-Veyriac; M. Aymard; J.P. Ortonne; F. Pouget; J. Revuz; J.M. Decazes; J.E. Malkin

Book ID: 104459786
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 297 KB
Volume: 144
Category: Article
ISSN: 0007-0963
DOI: 10.1046/j.1365-2133.2001.04139.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Valaciclovir Versus Aciclovir in Patient

Valaciclovir Versus Aciclovir in Patient Initiated Treatment of Recurrent Genital Herpes: A Randomised, Double Blind Clinical Trial

✍ Bodsworth, N.J.; Crooks, R.J.; Borelli, S.; Vejlsgaard, G.; Paavonen, J.; Worm, 📂 Article 📅 1998 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 218 KB

Once, twice, or three times daily famcic

Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial

✍ Stephen D. Shafran; Stephen K. Tyring; Richard Ashton; Jacque Decroix; Chistine 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Effect of Valacyclovir on Viral Shedding

Effect of Valacyclovir on Viral Shedding in Immunocompetent Patients With Recurrent Herpes Simplex Virus 2 Genital Herpes: A US-Based Randomized, Double-Blind, Placebo-Controlled Clinical Trial

✍ Fife, Kenneth H.; Warren, Terri J.; Ferrera, R. David; Young, Douglas G.; Justus 📂 Article 📅 2006 🏛 Mayo Clinic 🌐 English ⚖ 55 KB

504 A Double-Blind, Double-Dummy, Random

504 A Double-Blind, Double-Dummy, Randomized, Controlled, Multicenter Trial On the Efficacy and Safety of Azathioprine Vs mesalamine for Prevention of Clinical Relapses in Crohn's Disease Patients with Postoperative Moderate or Severe Endoscopic Recurrence

✍ Walter Reinisch; Sieglinde Angelberger; Wolfgang Petritsch; Klaus Herrlinger; Ol 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Efficacy and safety profiles of a new S(

Efficacy and safety profiles of a new S(—)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial

✍ Sung Ai Kim; Sungha Park; Namsik Chung; Do-Sun Lim; Joo-Young Yang; Byung-Hee Oh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Efficacy and Tolerability of Fimasartan,

Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension

✍ Sang Eun Lee; Yong-Jin Kim; Hae-Young Lee; Han-Mo Yang; Chang-Gyu Park; Jae-Joon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 806 KB